Comparisons of colon-cancer survival among European countries

The EUROCARE study

M. Santi, R. Capocaccia, A. Verdecchia, G. Gatta, A. Micheli, A. Mariotto, T. Hakulinen, F. Berrino

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Under the aegis of EUROCARE, a European Union project to assemble survival data from population-based cancer registries and analyze them according to standardized procedures, we have investigated and compared colon-cancer survival in 10 European contries. We analyzed 68,283 colon-cancer cases diagnosed between 1978 and 1985 and followed for at least 6 years. After calculating relative survival, putative factors prognostic for survival were investigated by univariate and multiple-regression analyses. Important intercountry colon-cancer survival differences exist within Europe, which are not explained by methodological differences, nor by demographic confounders. In patients aged 60 to 69, the mean European 5-year cumulative relative survival was 40%. Switzerland, Findland and The Netherlands had significantly higher 5-year relative survival, while one area in the UK and Cracow in Poland had significantly lower survival than this European estimate. Prognosis improved over time: from 1978 to 1985, the risk of death was reduced by about 4% per year in all countries studied. Age at diagnosis is inversely related to prognosis. Differences in health provision and hence in quality of care and stage at presentation seem largely responsible for the differences in colon-cancer survival found in the EUROCARE countries.

Original languageEnglish
Pages (from-to)43-48
Number of pages6
JournalInternational Journal of Cancer
Volume63
Issue number1
DOIs
Publication statusPublished - 1995

Fingerprint

Colonic Neoplasms
Survival
Quality of Health Care
European Union
Poland
Switzerland
Netherlands
Registries
Regression Analysis
Demography
Health
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Santi, M., Capocaccia, R., Verdecchia, A., Gatta, G., Micheli, A., Mariotto, A., ... Berrino, F. (1995). Comparisons of colon-cancer survival among European countries: The EUROCARE study. International Journal of Cancer, 63(1), 43-48. https://doi.org/10.1002/ijc.2910630109

Comparisons of colon-cancer survival among European countries : The EUROCARE study. / Santi, M.; Capocaccia, R.; Verdecchia, A.; Gatta, G.; Micheli, A.; Mariotto, A.; Hakulinen, T.; Berrino, F.

In: International Journal of Cancer, Vol. 63, No. 1, 1995, p. 43-48.

Research output: Contribution to journalArticle

Santi, M, Capocaccia, R, Verdecchia, A, Gatta, G, Micheli, A, Mariotto, A, Hakulinen, T & Berrino, F 1995, 'Comparisons of colon-cancer survival among European countries: The EUROCARE study', International Journal of Cancer, vol. 63, no. 1, pp. 43-48. https://doi.org/10.1002/ijc.2910630109
Santi, M. ; Capocaccia, R. ; Verdecchia, A. ; Gatta, G. ; Micheli, A. ; Mariotto, A. ; Hakulinen, T. ; Berrino, F. / Comparisons of colon-cancer survival among European countries : The EUROCARE study. In: International Journal of Cancer. 1995 ; Vol. 63, No. 1. pp. 43-48.
@article{f7bfb9b01cbe4236ac2c44d4c989c6e2,
title = "Comparisons of colon-cancer survival among European countries: The EUROCARE study",
abstract = "Under the aegis of EUROCARE, a European Union project to assemble survival data from population-based cancer registries and analyze them according to standardized procedures, we have investigated and compared colon-cancer survival in 10 European contries. We analyzed 68,283 colon-cancer cases diagnosed between 1978 and 1985 and followed for at least 6 years. After calculating relative survival, putative factors prognostic for survival were investigated by univariate and multiple-regression analyses. Important intercountry colon-cancer survival differences exist within Europe, which are not explained by methodological differences, nor by demographic confounders. In patients aged 60 to 69, the mean European 5-year cumulative relative survival was 40{\%}. Switzerland, Findland and The Netherlands had significantly higher 5-year relative survival, while one area in the UK and Cracow in Poland had significantly lower survival than this European estimate. Prognosis improved over time: from 1978 to 1985, the risk of death was reduced by about 4{\%} per year in all countries studied. Age at diagnosis is inversely related to prognosis. Differences in health provision and hence in quality of care and stage at presentation seem largely responsible for the differences in colon-cancer survival found in the EUROCARE countries.",
author = "M. Santi and R. Capocaccia and A. Verdecchia and G. Gatta and A. Micheli and A. Mariotto and T. Hakulinen and F. Berrino",
year = "1995",
doi = "10.1002/ijc.2910630109",
language = "English",
volume = "63",
pages = "43--48",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Comparisons of colon-cancer survival among European countries

T2 - The EUROCARE study

AU - Santi, M.

AU - Capocaccia, R.

AU - Verdecchia, A.

AU - Gatta, G.

AU - Micheli, A.

AU - Mariotto, A.

AU - Hakulinen, T.

AU - Berrino, F.

PY - 1995

Y1 - 1995

N2 - Under the aegis of EUROCARE, a European Union project to assemble survival data from population-based cancer registries and analyze them according to standardized procedures, we have investigated and compared colon-cancer survival in 10 European contries. We analyzed 68,283 colon-cancer cases diagnosed between 1978 and 1985 and followed for at least 6 years. After calculating relative survival, putative factors prognostic for survival were investigated by univariate and multiple-regression analyses. Important intercountry colon-cancer survival differences exist within Europe, which are not explained by methodological differences, nor by demographic confounders. In patients aged 60 to 69, the mean European 5-year cumulative relative survival was 40%. Switzerland, Findland and The Netherlands had significantly higher 5-year relative survival, while one area in the UK and Cracow in Poland had significantly lower survival than this European estimate. Prognosis improved over time: from 1978 to 1985, the risk of death was reduced by about 4% per year in all countries studied. Age at diagnosis is inversely related to prognosis. Differences in health provision and hence in quality of care and stage at presentation seem largely responsible for the differences in colon-cancer survival found in the EUROCARE countries.

AB - Under the aegis of EUROCARE, a European Union project to assemble survival data from population-based cancer registries and analyze them according to standardized procedures, we have investigated and compared colon-cancer survival in 10 European contries. We analyzed 68,283 colon-cancer cases diagnosed between 1978 and 1985 and followed for at least 6 years. After calculating relative survival, putative factors prognostic for survival were investigated by univariate and multiple-regression analyses. Important intercountry colon-cancer survival differences exist within Europe, which are not explained by methodological differences, nor by demographic confounders. In patients aged 60 to 69, the mean European 5-year cumulative relative survival was 40%. Switzerland, Findland and The Netherlands had significantly higher 5-year relative survival, while one area in the UK and Cracow in Poland had significantly lower survival than this European estimate. Prognosis improved over time: from 1978 to 1985, the risk of death was reduced by about 4% per year in all countries studied. Age at diagnosis is inversely related to prognosis. Differences in health provision and hence in quality of care and stage at presentation seem largely responsible for the differences in colon-cancer survival found in the EUROCARE countries.

UR - http://www.scopus.com/inward/record.url?scp=0028829649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028829649&partnerID=8YFLogxK

U2 - 10.1002/ijc.2910630109

DO - 10.1002/ijc.2910630109

M3 - Article

VL - 63

SP - 43

EP - 48

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -